We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

Small Molecule Drug Discovery

The process of small molecule drug discovery can be complex and challenging.  A typical workflow begins with hit identification and assay development, and carries through to preclinical candidate selection. High-throughput screening of drug candidates plays in essential role in the drug discovery process.

Promega offers a comprehensive selection of tools to accelerate drug discovery, based on an innovative, sensitive bioluminescence platform.



Solutions for Small Molecule Screening

Support for Contract Research Organizations (CROs)

Discover how Promega can help your CRO develop better solutions for your clients.

Learn More

NanoBRET™ Technology Powers Drug Discovery

Learn how Aurelia Bioscience used NanoBRET™ technology to measure kinase target engagement under more physiologically relevant conditions.

If you have questions or challenges with small molecule screening, we’re here to help.

Contact Us